Cargando…
Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation
Recurrent hepatitis C after orthotopic liver transplantation (OLT) is universal and can lead to graft failure and, consequently, reduced survival. Hepatitis C treatment can be used to prevent these detrimental outcomes. The aim of this study was to describe rates of hepatitis C recurrence and sustai...
Autores principales: | Zanaga, L.P., Vigani, A.G., Angerami, R.N., Giorgetti, A., Escanhoela, C.A.F., Ataíde, E.C., Boin, I.F.S.F., Stucchi, R.S.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264534/ https://www.ncbi.nlm.nih.gov/pubmed/28076451 http://dx.doi.org/10.1590/1414-431X20165540 |
Ejemplares similares
-
Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center
por: Zanaga, L.P., et al.
Publicado: (2019) -
Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
por: Zanaga, L.P., et al.
Publicado: (2016) -
Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors
por: Miotto, N., et al.
Publicado: (2016) -
Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C
por: Mendes, L.C., et al.
Publicado: (2016) -
Clinical and pathological challenges in the diagnosis of late-onset
biliary atresia: four case studies
por: Fontenele, J.P.U., et al.
Publicado: (2016)